Literature DB >> 29620747

Cancer researchers push to relax rules for clinical trials.

Heidi Ledford.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29620747     DOI： 10.1038/d41586-018-03355-6

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  3 in total

1.  Second malignancy in non-small cell lung cancer (NSCLC): prevalence and overall survival (OS) in routine clinical practice.

Authors:  Martin Faehling; Birgit Schwenk; Sebastian Kramberg; Sabine Fallscheer; Matthias Leschke; Jörn Sträter; Robert Eckert
Journal:  J Cancer Res Clin Oncol       Date:  2018-07-30       Impact factor: 4.553

2.  Impact of Prior Cancer History on the Clinical Outcomes in Advanced Breast Cancer: A Propensity Score-Adjusted, Population-Based Study.

Authors:  Caijin Lin; Jiayi Wu; Shuning Ding; Chihwan Goh; Lisa Andriani; Kunwei Shen; Li Zhu
Journal:  Cancer Res Treat       Date:  2019-11-18       Impact factor: 4.679

3.  Barriers to patient enrolment in phase III cancer clinical trials: interviews with clinicians and pharmaceutical industry representatives.

Authors:  Aniek Dane; Soedaba Ashraf; James Timmis; Monique Bos; Carin Uyl-de Groot; P Hugo M van der Kuy
Journal:  BMJ Open       Date:  2022-02-17       Impact factor: 2.692
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.